Oncosia Scientific Newsroom

Newsroom

Insights, Announcements & Partnership News

Insights

Market Insight 24 March 2025 12 min read

Radiopharmaceutical Therapy Is Growing Fast. Dosimetry Infrastructure Is Not Keeping Up.

The RPT market is expanding rapidly — from Lu-177 PSMA to Ac-225 alpha therapy. But dosimetry capability at clinical trial sites and routine departments has not kept pace. What that gap means and how to close it.

Read

Events

Nuclear Medicine 30 May–2 June 2026 Los Angeles, USA

SNMMI Annual Meeting 2026

Oncosia Scientific engaged with the North American nuclear medicine community at SNMMI 2026 — covering multi-nuclide dosimetry, the formal Radnostix distributor launch, and a live demonstration of the integrated EBRT + RLT workflow in PLANET® Dose.

Read
Nuclear Medicine 22–25 April 2026 Münster, Germany

64th Annual Meeting of the Deutsche Gesellschaft für Nuklearmedizin (DGN) 2026

Oncosia Scientific's first exhibition presence at DGN — presenting PLANET® Dose, end-to-end clinical trial dosimetry services, and Radnostix calibration & reference sources at Booth A12 in Münster.

Read
Nuclear Medicine 21–23 May 2026 Łódź, Poland

XIX National Scientific Congress of the Polish Society of Nuclear Medicine (PTMN) 2026

Oncosia Scientific attended the XIX PTMN Congress in Łódź, contributing patient datasets and PLANET® Dose by DOSIsoft for a live ¹⁷⁷Lu Dosimetry Workshop — covering AI-assisted segmentation, multi-timepoint approaches, and partial volume effect correction.

Read

Press Releases

Research Funding 9 September 2026 3 min read

Oncosia Scientific Receives Forschungszulage Grant for ²²⁵Ac Dosimetry Development

Grant funds a validated end-to-end dosimetry workflow for targeted alpha therapies — covering phantom-validated system modelling, Monte Carlo modelling of the ²²⁵Ac daughter emission spectrum, low-count reconstruction, and parent–daughter kinetic modelling.

Read
Partnership April 2026 3 min read

Oncosia Scientific Becomes First Authorised German Distributor of Radnostix Calibration & Reference Products

Radnostix, Inc. and Oncosia Scientific GmbH announce a distribution agreement making Oncosia Scientific the first authorised distributor of Radnostix calibration and reference products in Germany.

Read
Market Update 6 April 2026 8 min read

Oncosia Establishes Meaningful Foothold in Türkiye: A Growing Market for Personalised Dosimetry

One year after market entry, Oncosia reports first clinical installations, new isotope qualifications, ¹⁶¹Tb trial site qualifications, and a deepening partnership with Siemens Healthineers — with a first clinical publication from Çukurova University.

Read
Partnership 16 July 2025 3 min read

Oncosia Scientific and DOSIsoft Partner to Expand PLANET® Onco Dose in Germany and Türkiye

DOSIsoft SA and Oncosia Scientific GmbH announce their partnership to commercialize and distribute PLANET® Onco Dose across German and Turkish markets — with a shared mission to elevate personalized dosimetry in nuclear medicine.

Read